Form 4: Hims & Hers Health Executive Michael Chi Executes Stock Options and Sells Shares Under 10b5-1 Plan

Chief Commercial Officer Michael Chi exercised stock options and sold shares of Hims & Hers Health, Inc. under a pre-arranged Rule 10b5-1 trading plan.

Summary

• Michael Chi, Chief Commercial Officer of Hims & Hers Health, Inc., executed stock options to purchase 7,500 shares of Class A Common Stock at a price of $13.90 on December 19, 2024.
• On the same day, Chi sold 7,500 shares of Class A Common Stock at a price of $26.00.
• These transactions were conducted under a Rule 10b5-1 trading plan adopted on March 1, 2024.
• Following these transactions, Chi directly owns 193,601 shares of Class A Common Stock.
• Chi also directly owns 51,582 derivative securities in the form of stock options.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the document simply reports insider trading activity under a pre-arranged plan. It doesn't inherently indicate positive or negative performance for the company.

Industry Context

This filing is a routine disclosure of insider transactions and provides transparency to the market regarding executive stock ownership. The use of a 10b5-1 plan is a common practice to avoid accusations of trading on inside information.

Comparison to Industry Standards

• Executive stock option exercises and sales are common across publicly traded companies, particularly in the tech and healthcare sectors.
• The use of Rule 10b5-1 trading plans is a standard practice to ensure compliance with insider trading regulations, similar to practices at companies like Teladoc or GoodRx.
• The vesting schedule of the options (25% after one year, then monthly) is a typical arrangement for employee stock options.

Stakeholder Impact

• The transactions have a minimal impact on stakeholders as they represent a small portion of the outstanding shares and were conducted under a pre-arranged trading plan.

Key Dates